The understanding of the pion structure as described in terms of transverse-momentum-dependent parton distribution functions (TMDs) is of importance for the interpretation of currently ongoing Drell-Yan experiments with pion beams. In this work we discuss the description of pion TMDs beyond leading twist in a pion model formulated in the light-front constituent framework. For comparison, we also review and derive new results for pion TMDs in the bag and spectator model.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501201 | PMC |
http://dx.doi.org/10.1140/epjc/s10052-016-4257-8 | DOI Listing |
Phys Rev Lett
December 2024
School of Physics and Center of High Energy Physics, Peking University, Beijing 100871, China.
The BESIII Collaboration recently performed a precise measurement of the e^{+}e^{-}→DD[over ¯] Born cross sections, and confirmed the G(3900) structure reported by BABAR and Belle with high significance. We identify the G(3900) as the first P-wave DD[over ¯]^{*}/D[over ¯]D^{*} molecular resonance. The experimental and theoretical identification of the P-wave dimeson state holds paramount importance in enhancing our comprehension of the nonperturbative QCD and few-body physics.
View Article and Find Full Text PDFIUCrdata
September 2024
University of Mainz, Department of Chemistry, Duesbergweg 10-14, 55099 Mainz, Germany.
In the title compound, CHBFNO, a highly fluorescent boron-dipyrromethene dye, the methyl-propionate moieties have different conformations. In the crystal, weak C-H⋯F and C-H⋯O inter-actions link the mol-ecules. Some optical properties are presented.
View Article and Find Full Text PDFFront Immunol
October 2024
Group of Advanced Immuno-Regulation (GIRA), Gregorio Marañon Health Research Institute Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Gregorio Marañon, Madrid, Spain.
Introduction: Immunotherapy has revolutionized cancer treatment, and Chimeric Antigen Receptor T cell therapy (CAR-T) is a groundbreaking approach. Traditional second-generation CAR-T therapies have achieved remarkable success in hematological malignancies, but there is still room for improvement, particularly in developing new targeting strategies. To address this limitation, engineering T cells with multi-target universal CARs (UniCARs) based on monomeric streptavidin has emerged as a versatile approach in the field of anti-tumor immunotherapy.
View Article and Find Full Text PDFMult Scler Relat Disord
November 2024
Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China. Electronic address:
Purpose: The retinal microvascular network plays a crucial role in inflammatory injury in paediatric optic neuritis (PON) with serum MOG antibody positivity (MOG + PON). This study compared retinal microvascular densities and structural alterations in MOG + PON eyes with paediatric isolated optic neuritis (PION) eyes and followed up with the final best-corrected visual acuity (BCVA) after 6 months.
Methods: A total of 29 children (52 eyes) with PON, including 15 MOG + PON cases (28 eyes), 6 PION cases (10 eyes), 2 neuromyelitis optica spectrum disorders associated PON(NMOSD-PON) cases (4 eyes), 6 MOG-associated disease (MOGAD) patients without ON-affected eyes (MOG + NPON) cases (10 eyes) and age- and gender-matched healthy controls (HCs) underwent superficial/deep retinal angiography density (SAD/DAD) by optical coherence tomography angiography (OCTA).
Phys Rev Lett
June 2024
Brookhaven National Laboratory (BNL), Upton, New York 11973, USA.
We present a first search for dark-trident scattering in a neutrino beam using a dataset corresponding to 7.2×10^{20} protons on target taken with the MicroBooNE detector at Fermilab. Proton interactions in the neutrino target at the main injector produce π^{0} and η mesons, which could decay into dark-matter (DM) particles mediated via a dark photon A^{'}.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!